Disease Modification and Symptom Relief in Osteoarthritis Using a Mutated GCP-2/CXCL6 Chemokine

The authors revealed that the CXCR2 ligand granulocyte chemotactic protein 2 was expressed, during embryonic development, within the prospective permanent articular cartilage, but not in the epiphyseal cartilage destined to be replaced by bone.